As of the latest SEC filings, Lakefront Biotherapeutics NV (LKFT) is held by 13 institutional funds. The largest fund shareholder is Columbia Overseas Value Fund (COAVX), holding an estimated $24,058,384.02 in market value, representing 0.35% of its portfolio.
Funds holding Lakefront Biotherapeutics NV (LKFT)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- LKFT
- CIK:
- 0001421876
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
COAVX
Columbia Overseas Value Fund
|
MF | Columbia Threadneedle | 0.35% | $24,058,384.02 | 714,747 | Feb 28, 2026 | Apr 27, 2026 |
|
-
Columbia Variable Portfolio - Overseas Core Fund
|
ETF | Columbia Threadneedle | 0.28% | $10,396,470.00 | 346,549 | Mar 31, 2026 | May 28, 2026 |
|
IBB
iShares Biotechnology ETF
|
ETF | BlackRock / iShares | 0.10% | $8,156,790.00 | 271,893 | Mar 31, 2026 | May 28, 2026 |
|
COSAX
Columbia Overseas Core Fund
|
MF | Columbia Threadneedle | 0.30% | $3,052,861.02 | 90,697 | Feb 28, 2026 | Apr 27, 2026 |
|
SBHVX
SBH SMALL CAP VALUE FUND
|
MF | Independent / Boutique | 0.73% | $2,824,560.00 | 94,152 | Mar 31, 2026 | May 29, 2026 |
|
SBIO
ALPS Medical Breakthroughs ETF
|
ETF | Independent / Boutique | 1.42% | $1,965,306.42 | 58,387 | Feb 28, 2026 | Apr 29, 2026 |
|
-
Variable Portfolio - Partners Small Cap Value Fund
|
ETF | Columbia Threadneedle | 0.34% | $1,376,670.00 | 45,889 | Mar 31, 2026 | May 28, 2026 |
|
VCFVX
International Value Fund
|
MF | Corebridge / VALIC | 0.18% | $903,232.44 | 26,834 | Feb 28, 2026 | Apr 29, 2026 |
|
SWMIX
Schwab International Opportunities Fund
|
MF | Charles Schwab | 0.06% | $634,217.87 | 22,789 | Apr 30, 2026 | Jun 25, 2026 |
|
FNCMX
Fidelity Nasdaq Composite Index Fund
|
MF | Fidelity | 0.00% | $264,264.66 | 7,851 | Feb 28, 2026 | Apr 24, 2026 |
|
IMRFX
Columbia Global Opportunities Fund
|
MF | Columbia Threadneedle | 0.03% | $95,067.28 | 3,416 | Apr 30, 2026 | Jun 25, 2026 |
|
IBBQ
Invesco Nasdaq Biotechnology ETF
|
ETF | Invesco | 0.04% | $27,028.98 | 803 | Feb 28, 2026 | Apr 28, 2026 |
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
ETF | ProShares | 0.02% | $22,484.88 | 668 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)